Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Fast-growings companies in Liquid biopsy
by Most Patent Filing In 3 Years in the China in 2022

The Liquid biopsy top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filing In 3 Years Liquid biopsy Fast-growings in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
A liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, primarily blood. Like traditional biopsy this type of technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer, with the added benefit of being largely non-invasive. Therefore, it can also be done more frequently which can better track tumors and mutations over a duration of time. It may also be used to validate the efficiency of a cancer treatment drug by taking multiple liquid biopsy samples in the span of a few weeks. The technology may also prove beneficial for patients after treatment to monitor relapse.
#
Company Name
Region
Tech Topics
Total
1
Genecast Biotechnology Co. Ltd.
Patent: 3
2
Patent: 3
3
Patent: 2
4
Patent: 2
5
Patent: 2
6
Health care,Drug,Electronic nose,
...[+2]
Patent: 2
7
Patent: 1
8
Patent: 1
9
Patent: 1
10
Library science,Cultural background,Literature,
...[+2]
Patent: 1
11
Patent: 1
12
Patent: 1
13
Patent: 1
14
Patent: 1
15
Patent: 1
16
Western culture,TUTOR,Silicon carbide,
...[+2]
Patent: 1
17
PHASE Scientific International Ltd.
Patent: 1
18
CONTEST,Biological membrane,Biofabrication,
...[+2]
Patent: 1
19
Patent: 1
20
3D Biomedicine Science & Technology Co., Ltd.
Patent: 1
Page generation time: May 12 2025